ICU Non Current Liabilities Total from 2010 to 2024

ICUI Stock  USD 168.84  1.25  0.75%   
ICU Medical's Non Current Liabilities Total is increasing with slightly volatile movements from year to year. Non Current Liabilities Total is estimated to finish at about 1.9 B this year. For the period between 2010 and 2024, ICU Medical, Non Current Liabilities Total quarterly trend regression had mean deviation of  583,121,179 and range of 1.9 B. View All Fundamentals
 
Non Current Liabilities Total  
First Reported
1992-12-31
Previous Quarter
1.7 B
Current Value
1.7 B
Quarterly Volatility
587 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check ICU Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ICU Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 263.2 M, Interest Expense of 107.9 M or Total Revenue of 2.4 B, as well as many indicators such as Price To Sales Ratio of 1.01, Dividend Yield of 0.0 or PTB Ratio of 1.08. ICU financial statements analysis is a perfect complement when working with ICU Medical Valuation or Volatility modules.
  
Check out the analysis of ICU Medical Correlation against competitors.
For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.

Latest ICU Medical's Non Current Liabilities Total Growth Pattern

Below is the plot of the Non Current Liabilities Total of ICU Medical over the last few years. It is ICU Medical's Non Current Liabilities Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ICU Medical's overall financial position and show how it may be relating to other accounts over time.
Non Current Liabilities Total10 Years Trend
Slightly volatile
   Non Current Liabilities Total   
       Timeline  

ICU Non Current Liabilities Total Regression Statistics

Arithmetic Mean397,595,570
Geometric Mean33,112,723
Coefficient Of Variation190.07
Mean Deviation583,121,179
Median63,930,000
Standard Deviation755,696,223
Sample Variance571076.8T
Range1.9B
R-Value0.71
Mean Square Error300790.2T
R-Squared0.51
Significance0
Slope120,783,192
Total Sum of Squares7995074.9T

ICU Non Current Liabilities Total History

20241.9 B
20231.8 B
20221.9 B
202163.9 M
202065.9 M
201966.7 M
201872.4 M

About ICU Medical Financial Statements

Investors use fundamental indicators, such as ICU Medical's Non Current Liabilities Total, to determine how well the company is positioned to perform in the future. Although ICU Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Non Current Liabilities Total1.8 B1.9 B

Currently Active Assets on Macroaxis

When determining whether ICU Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ICU Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Icu Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Icu Medical Stock:
Check out the analysis of ICU Medical Correlation against competitors.
For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICU Medical. If investors know ICU will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICU Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.24)
Earnings Share
(4.56)
Revenue Per Share
96.302
Quarterly Revenue Growth
0.065
Return On Assets
0.0066
The market value of ICU Medical is measured differently than its book value, which is the value of ICU that is recorded on the company's balance sheet. Investors also form their own opinion of ICU Medical's value that differs from its market value or its book value, called intrinsic value, which is ICU Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICU Medical's market value can be influenced by many factors that don't directly affect ICU Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICU Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICU Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICU Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.